| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. [PubChem] |
| Indication |
For the treatment of asthma and chronic obstructive pulmonary disease (COPD). |
| Pharmacology |
Procaterol is a long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. |
| Toxicity |
Symptoms of overdose include angina (chest pain), dizziness, dry mouth, fatigue, flu-like symptoms, headache, heart irregularities, high or low blood pressure, high blood sugar, insomnia, muscle cramps, nausea, nervousness, rapid heartbeat, seizures, and tremor. |
| Affected Organisms |
| • |
Humans and other mammals |
|
| Absorption |
Because of the small therapeutic dose, systemic levels of salmeterol are low or undetectable after inhalation of recommended doses. |
|